Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Pantoprazole Sodium Enteric-Coated Tablets
Tablets · 20mg; 40mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB961)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ibuprofen Sustained-Release Capsules
Capsules · 0.3g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB960)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lacidipine Tablets
Tablets · 4mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB959)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Cilnidipine Tablets
Tablets · 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB958)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Crisaborole Cream
Cream · 2% (30g:0.6g)
- Therapy
- Others > Dermatology
- Status
- Official FDF licensing catalog (UB957)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Flurbiprofen Cataplasms
Cataplasms · 12g:40mg (13.6cm*10cm)
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB956)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dapagliflozin Tablets
Tablets · 10mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB955)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Amlodlpine Beaylate Tablet
Tablet · 5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB953)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Telmisartan Capsule
Capsule · 40mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB952)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Roxithromycin dispersible capsule
capsule · 0.15g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB951)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Azithromycin Capsule
Capsule · 0.25g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB950)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Gemfibrozil Capsule
Capsule · 0.3g
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB949)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Telmisartan and Hydrochlorothiazide Tablet
Tablet · 40mg:12.5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB948)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Doxazosin Mesylate Tablet
Tablet · 2mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB947)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Domperidone Tablet
Tablet · 10mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB946)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Terazosin Hydrochloride Tablet
Tablet · 2mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB945)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Paracetamol Tablet
Tablet · 0.5g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB944)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clozapine Tablet
Tablet · 25mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB943)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ketotifen Fumarate Tablet
Tablet · 1mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB942)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Thalidomide Tablet
Tablet · 25mg, 50mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB941)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ursodeoxycholic Acid Tablet
Tablet · 50mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB940)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Folic Acid Tablet
Tablet · 0.4mg, 5mg
- Therapy
- Others > Hematology
- Status
- Official FDF licensing catalog (UB939)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Compound Aminopyrine Phenacetin Tablet
Tablet · 0.15g:0.15g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB938)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ibuprofen Tablet
Tablet · 0.1g
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB937)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Prazosin Hydrochloride Tablet
Tablet · 1mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB936)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Propafenone Hydrochloride Tablet
Tablet · 50mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB935)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Metformin Hydrochloride Tablet
Tablet · 0.25g
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB934)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clonidine Hydrochloride Tablet
Tablet · 0.075mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB933)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Compound Dihydralazine Sulfate Tablet
Tablet · 12.5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB932)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Compound Reserpine Tablet
Tablet
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB931)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Enalapril Maleate Tablet
Tablet · 5mg, 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB930)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sotalol Hydrochloride Tablet
Tablet · 80mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB929)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Catopril and Hydrochlorothiazide Compound
— · 10mg:6mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB928)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Hydrochlorothiazide Tablet
Tablet · 25 mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB927)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Apixaban Tablet
Tablet · 2.5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB926)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lenalidomide Capsule
Capsule · 5mg, 10mg, 25mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB925)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Resmetirom Tablet
Tablet · 60mg, 80mg, 100mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB924)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Upadacitinib Sustained-release Tablet
Tablet · 15mg, 30mg, 45mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB923)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Elagolix Sodium Tablet
Tablet · 150mg, 200mg
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB922)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Capivasertib Tablet
Tablet · 160mg, 200mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB921)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Etrasimod Tablet
Tablet · 0.5mg, 2mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB920)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Venetoclax Tablet
Tablet · 10mg, 50mg, 100mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB919)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Finerenone Tablet
Tablet · 10mg, 20mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB918)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Darolutamide Tablet
Tablet · 300mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB917)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Abemaciclib Tablet
Tablet · 50mg, 100mg, 150mg, 200mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB916)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Vericiguat Tablet
Tablet · 2.5mg, 5mg, 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB915)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Abrocitinib Tablet
Tablet · 50mg; 100mg; 200mg
- Therapy
- Others > Dermatology
- Status
- Official FDF licensing catalog (UB914)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sacubitril Valsartan Sodium Tablet
Tablet · 24/26mg; 49/51mg; 97/103mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB913)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Page 1 / 19Next ›